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Abstract Fatty acids, especially those from phospholipids
(PLFA), are essential membrane components that are present
in relatively constant proportions in biological membranes un-
der natural conditions. However, under harmful growth condi-
tions, such as diseases, environmental changes, and chemical
exposure, the fatty acid proportions might vary. If such changes
could be identified and revealed to be specific for adverse
situations, they could be used as biomarkers. Such biomarkers
could facilitate the identification of virulence and resistance
mechanisms to particular chemotherapeutic agents. Therefore,
specific biomarkers could lead to better therapeutic decisions
that would, in turn, enhance treatment effectiveness. The ob-
jective of this study was to compare the fatty acid profiles of
trivalent antimony and nitric oxide (NO)-resistant and -sensitive
Leishmania chagasi and Leishmania amazonensis isolates.
Fatty acid methyl esters (FAMEs) were obtained from total
lipids (MIDI), ester-linked lipids (ELFA), and ester-linked
phospholipids (PLFA). FAMEs were analyzed by chromatog-
raphy and mass spectrometry. Species- or resistance-associated
differences in FAME profiles were assessed by nonmetric
multidimensional scaling, multiresponse permutation proce-
dures, and indicator species analyses. The isolate groups had
different MIDI-FAME profiles. However, neither the ELFA nor
PLFA profiles differed between the sensitive and resistant
isolates. Levels of the fatty acid 18:1 Δ9c were increased in
sensitive isolates (p <0,001), whereas the fatty acid 20:4Δ5,8,
11,14 showed the opposite trend (p <0.01). We conclude that
these two fatty acids are potential biomarkers for NO and
antimony resistance in L. chagasi and L. amazonensis and that
they could be helpful in therapeutic diagnoses.
Introduction
Leishmaniasis represents a spectrum of diseases that affect
over 12 million people worldwide according to the World
Health Organization (WHO) (2010). Although it has a major
impact on public health, especially in developing countries,
effective treatments for this “neglected” disease are still lack-
ing (Hotez et al. 2007). In addition, the first-choice drugs—the
pentavalent antimonials—require cautious administration un-
der clinical and laboratory monitoring due to toxic side effects
such as nephrotoxicity, cardiotoxicity, hepatotoxicity, and fa-
tal arrhythmias (Rath et al. 2003; Ouelette et al. 2004).
Leishmaniasis is caused byLeishmania spp., a kinetoplastide
protozoan that lives as a flagellate form (promastigote) in the
midgut of its sandfly vector. After transmission to a vertebrate
host, typically a human or dog, Leishmania are converted into
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amastigote forms. Depending on the Leishmania species, the
disease can be presented in various clinical forms such as
cutaneous, mucocutaneous, and visceral.
Nitric oxide (NO), a free radical generated in macrophages
by the nitric oxide synthase enzyme (iNOS), is a microbicidal
molecule produced to control infections. Several studies have
demonstrated the antiparasitic effects of NO against Leishmania
(Mauel and Ransjin 1997). Nonetheless, Leishmania were ob-
served to reduce endogenous NO production, and some isolates
were found to be naturally resistant to nitric oxide (Giudice et al.
2007; Santos et al. 2012). Isolates resistant to available leish-
maniasis treatment drugs such as antimony (Croft et al. 2006)
have also been reported. Additionally, there are isolates that are
resistant to both antimonies and NO, suggesting a common
resistance pathway (Holzmuller et al. 2005).
Studies that employed a metabolomics approach as a tool
to analyze the diversity of Leishmania isolates are emerging
(Scheltema et al. 2010). T'Kindt et al. (2010) characterized
clinical Leishmania donovani isolates that were resistant or
not to sodium stibogluconate. The authors found that lipids
comprised the largest class of identified metabolites and that
the differences in the phospholipid and sphingolipid contents
were the main differences observed between the phenotypes.
According to Zhang and Beverley (2010), these two lipid
classes are both abundant and critical to virulence and viability
in Leishmania .
Fatty acid analysis is a method of studying lipids.
Piotrowska-Seget and Mrozik (2003) reported that polyunsat-
urated fatty acids are rare in bacterial membranes and might be
common in eukaryotes. According to Adosraku et al. (1993),
polyunsaturated fatty acids represent a large proportion of the
total lipids in Leishmania . Moreover, Alloatti and Uttaro
(2011) emphasized the role of polyunsaturated fatty acids in
cellular maintenance, especially in trypanosomatid membranes.
Interestingly, in L. donovani , the fatty acids from phospha-
tidylcholine and phosphatidylethanolamine were found to
differ in drug-resistant strains compared to sensitive strains.
Additionally, polyunsaturated fatty acids from phosphatidyl-
choline were shown to be present in higher amounts in
antimony-resistant isolates compared to sensitive isolates
(T'Kindt et al. 2010).
Currently, fatty acids are used as biomarkers for different
groups of microorganisms such as fungi, bacteria, and actino-
myces, among others. The fatty acids 11Me19:1 and 18:2ω6,
9 can be used as biomarkers of Vibrio cholera (Guckert et al.
1986). Fatty acid biomarkers can also indicate starvation or
stationary growth phase in bacteria (Guckert et al. 1986;
Piotrowska-Seget and Mrozik 2003). Furthermore, fatty acids
are key molecules that can indicate clinical conditions such as
drug resistance in infectious parasites (Mohanty et al. 2012).
Therefore, clinically useful biomarkers can help to identify
pathogenic organisms that are resistant to particular chemo-
therapeutic agents. To make treatments more effective,
specific biomarkers could lead to better therapeutic decisions
with regard to candidate drugs and their indications. Thus, our
hypothesis is that antimony and NO-resistant and -sensitive
strains of Leishmania chagasi and Leishmania amazonensis
will present with different fatty acid profiles that could lead to
the identification of a fatty acid-resistance biomarker in these
organisms. In this study, fatty acid profiling of antimony
(Trivalent antimony®) and NO-resistant and -sensitive L.
chagasi and L. amazonensis isolates was performed
according to ELFAME, phospholipid fatty acids (PLFA),
and MIDI procedures.
Material and methods
Parasites
Isolates of nitric oxide and trivalent antimony-resistant and -
sensitive L. chagasi (n =10) and L. amazonensis (n =2) were
selected from the Leishmania bank of the Molecular Biology
Laboratory of the Universidade Federal de Sergipe (UFS)
Medicine Department (Table 1). L. chagasi were isolated
from patients with visceral leishmaniasis at the UFS hospital.
The local ethics committee approved all procedures used in
this study (CAAE 0151.0.107.000–07). L. amazonensis iso-
lates were obtained from a Leishmania bank at the
Immunology Laboratory of HUPES, Universidade Federal
da Bahia. The viability of L. amazonensis and L. chagasi in
response to NO was previously determined by Giudice et al.
(2007) and Santos et al. (2012), respectively. The viability of
L. chagasi in response to antimony was evaluated by direct
cell counting. Briefly, exponentially growing parasites (1×
106 mL) were seeded in 96-well microplate (100 μL or 105
parasites/well) in the presence of SbIII (Sigma Chemical Co.,
St. Louis, MO, USA ), in concentrations varying of 250–3,
Table 1 Characterization of L. chagasi e L. amazonensis isolates for
resistance/sensitivity to NO and trivalent antimony
Isolates NO Antimony
L. chagasi HU UFS 02 − −
HU UFS 07 − −
HU UFS 09 + +
HU UFS 14 + +
HU UFS 15 + +
HU UFS 17 − −
HU UFS 23 + +
HU UFS 49 + +
L. amazonensis LTCP 9667 − +
LTCP 10432 + +
+ resistant, − sensitive
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000 μM for 48 h.Wells without SBIII was used as control and
considered 100 % of viability.
Parasite growth conditions and sample preparation
L. chagasi and L. amazonensis promastigotes were thawed
and cultured in biphasic Novy–MacNeal–Nicolle (NNN)
blood agar. Next, cultures were initiated by inoculating 1×
105 promastigotes into Schneider's insect medium, supple-
mented with heat-inactivated fetal bovine serum FBS (20 %)
and penicillin (1 %). The cultures were kept in an incubator at
24±1 °C and until they reached the stationary growth phase.
Fatty acids extraction
The stationary growth phase promastigotes (5×108 cells mL−1
in 50 mL) were centrifuged at 2,608×g , 4 °C for 10 min. The
supernatant was discarded, and the pellet was washed twice
with phosphate-buffered saline (PBS). Subsequently, the sam-
ples were lyophilized and used in cell fatty acid extractions.
All growth experiments and analyses were performed in
triplicate.
MIDI commercial procedure for the extraction of total fatty
acids (MIDIFA)
The MIDI procedure followed the steps described by Sasser
(1990). Briefly, lyophilized samples were treated with a 3.75-
M NaOH solution, in equal parts, water and methanol and
vortexed and heated for 30 min in a water bath. After incuba-
tion, 2 mL of a mixture of 6 M acetic acid and methanol
(1:0.85) and 3mL of hexanewere added to the tubes, followed
by homogenization and centrifugation (2,608×g , 10 °C for
10 min). The organic phase was aspirated and 1 mL of 0.3 M
NaOH was added to this phase with subsequent vortexing.
The samples were dried with ultrapure nitrogen and resus-
pended in 270 μL hexane.
Ester-linked fatty acids
This method followed the steps described by Schutter and
Dick (2000) and resulted in the formation of fatty acid methyl
esters (FAMEs) from all ester-linked fatty acids (ELFA) pres-
ent in the cells. For this procedure, 3.3 mL of a methanolic
KOH solution (0.2 M) were added to the cell pellet. Samples
were incubated in a water bath (37 °C) for 60 min, with a
vortexing step of approximately 15 s every 15 min throughout
the incubation period. Subsequently, 2 mL of 1 M acetic acid
were added to each sample, and the contents were homoge-
nized by vortexing for 5 min. After the addition of 2.2 mL of
hexane, the vortexing step was repeated, followed by an
interval of 10 min for phase separation. The samples were
centrifuged (480×g , 10 °C for 10 min), and the lipid fractions
were removed and dried under ultrapure nitrogen atmosphere.
Additional hexane (250 μL) was added, and the samples were
again homogenized.
Phospholipid fatty acids
This procedure followed the method described by Bligh and
Dyer (1959) for total lipid extraction. In this procedure, the
samples were first prepared for total lipid extraction. First, the
cell pellets were dissolved in 2 mL of 100 mM phosphate
buffer, 5 mL of methanol, and 2.5 mL of chloroform, agitated
in a shaker for 2 h and centrifuged (805×g , 10 °C for 12 min).
Next, the samples were filtered through Whatman #1 paper
over glass funnels. Next, 5 mL of methanol and 2.5 mL of
chloroform were added again, and the samples were homog-
enized on a vortex; this step was repeated once more. Then,
7.5 mL of 2 M NaCl were added, and the chloroform phase
was transferred and dried with ultrapure nitrogen.
Second, the lipid separation was performed with silica
columns, according to Buttler et al. (2003). The dried lipids
were dissolved in 1 mL of chloroform and loaded onto the
columns. The neutral phase was removed with chloroform, the
glycolipids with acetone and the phospholipids, our fraction of
interest, with methanol. The drying procedure was repeated.
Finally, the dried phospholipids were dissolved in 1 mL of
a 1:1 methanol: toluene solution while vortexing. Next, 1 mL
of 0.2 M KOH was added to each sample, and the samples
were heated in a water bath (38–48 °C) for 15 min. Then,
2 mL of deionized water, 0.3 mL of 1 M acetic acid, and
0.5 mL of hexane were added, and the samples were homog-
enized by vortexing. After phase separation, the hexane frac-
tion was removed, and the same amount of hexane was added
and removed twice. The hexane extract was dried under
ultrapure nitrogen and the methyl esters were redissolved in
hexane (270 μL).
Fatty acid methyl esters analysis
FAME analysis was performed in a Perkin Elmer Clarus 500
Gas Chromatograph that was programmed to run the follow-
ing conditions for all experiments: a run temperature of 120–
270 °C with an increase of 4 °C per minute, an injector
temperature of 220 °C, and a detector temperature of
280 °C. Furthermore, the Perkin Elmer Elite-5 column
(crossbond 5 % diphenyl/95 % dimethyl polysiloxane; cat
#N9316076; serial #862923) was used.
Data processing and statistical analysis
The fatty acid analysis was performed with the available gas
chromatograph program, the TotalChrom navigator—Clarus
500. The fatty acid profile of each sample was inferred with
the multivariate ordination technique. Prior to the ordination,
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the molar masses of each fatty acid (FAMES) in a sample
(shown as peak chromatograms) were determined, and the
samples were relativized by the sum of the weights of all
present fatty acids. Thus, the FAMESwere converted to molar
percentages of total peaks (mol%). The fatty acid profiles of
Leishmania isolates were next analyzed by nonmetric multi-
dimensional scaling (NMS) (McCune and Grace 2002), using
the PC-ORD program (MJM Software Design, Gleneden
Beach, OR, USA). The T test was used to evaluate the
hypothesis that the fatty acid compositions differed among
the species and isolates of NO and antimony-sensitive or -
resistant Leishmania , and a multivariate hypothesis test of the
multivariate nondifferences between treatments (multiresponse
permutation procedure (MRPP)) (Mielke and Berry 2000) was
used. Finally, to identify the specific fatty acid to be used as a
biomarker of resistant or sensitive isolates or to identify a
species biomarker, the indicator species analysis (ISA) was
used (Dufrene and Legendre 1997). The ISA provides an
indicator value (IV), ranging from 0–100, that expresses the
degree of relationship between the peak (fatty acid) and each
group (species or resistance/sensitivity). This value is the prod-
uct of the FAME relative abundance (amount of FAME in a
given group relative to its amount across all groups) and relative
frequency (number of samples in which the FAME was detect-
ed relative to the number of total samples within a given group).
IVs were tested for statistical significance in a randomization
procedure (Monte Carlo Test).
Mass spectrometry
The GC/MS analyses were performed on a GC-MS/FID (GC-
2010 Plus; GCMS-QP2010 Ultra, Shimadzu Corp., Kyoto,
Japan) equipped with an AOC-20i autosampler (Shimadzu).
The separations were performed on an Rtx ®-5MS Restek
fused silica capillary column (5 % diphenyl/95 % dimethyl
polysiloxane) with a 30 m×00.25 mm internal diameter (d.i.)
and a 0.25-μm-thick film with a constant helium (99.999 %)
flow rate of 1.2 mL min−1. An injection volume of 0.5 μL
(5 mg mL−1) was used with a split ratio of 1:10. The oven
temperature was programmed at 50 °C (isotherm for 1.5 min)
with an increase of 4 °C/min up to 200 °C, another increase of
10 °C/min up to 250 °C, and a final 5 min isotherm at 250 ° C.
The MS and FID data were acquired simultaneously with a
detector separation system, and the flow split ratio was 4:1
(MS:FID). A restrictor tube of 0.62m×0.15mm d.i. (capillary
column) was used to connect the splitter to the detector MS; a
restrictor tube of 0.74 m×00.22 mm d.i. was used to connect
the splitter to the FID detector. The injector temperature was
250 °C, and the ion source temperature was 200 °C. Mass
spectra were generated at 70 eV with a scan rate of 0.3 s scan,
and the fragments were detected in the range of 40–350 Da.
The FID temperature was adjusted to 250 °C, and the gasses
supplied to the FID were synthetic air, hydrogen, and helium
at flow rates of 30, 300, and 30 mL min−1, respectively. Each
constituent quantification was estimated by normalizing the
peak area generated in the FID (percentage). The compound
concentrations were calculated from the GC peak areas and
arranged in the order of elution from the GC.
Component identification was performed on the basis of
mass spectroscopy (MS) fragmentation pattern and retention
index analyses in comparison with bacterial acid methyl ester
mix (BAME) patterns, SUP 37 from Supelco®, and polyun-
saturated fatty acids (PUFA) from Sigma®. Three equipment
libraries, WILEY8, NIST107, and NIST21, that permitted
comparisons of spectral data with those contained in the
libraries at a similarity index of 80 % were also used.
Results
The experiments were conducted with eight Leishmania
chagasi and two L. amazonensis isolates, classified in accor-
dance with Table 1. Isolate viability experiments in response
to NO and antimony were performed to confirm the report by
Holzmuller et al. (2005) that indicated a strong correlation
between NO and antimony resistance. Other studies also
reported the existence of isolates resistant to both NO and
antimonial drugs (Croft et al. 2006; Holzmuller et al. 2006;
Giudice et al. 2007; T'Kindt et al. 2010; Santos et al. 2012).
Santos et al. (2012) further observed that L. chagasi isolates
that were refractory to antimony treatment showed higher
levels of NO resistance. Common pathways for the actions
of NO and antimonials have been reported. Sudhandiran and
Shaha (2003) suggested that antimonial activity could be
directly related to the induction of compounds such as NO.
Holzmuller et al. (2005) stated that some biochemical targets
such as thiol groups are common to the mechanisms of anti-
mony and NO resistance.
The isolates were grown until reaching the stationary
growth phase to determine the fatty acid profiles. The three
methods used to produce the FAMEs differed in the extraction
procedures. ELFA is based on a direct mild alkaline
methanolysis of the samples (Schutter and Dick 2000). In
PLFA, total lipids are first extracted, after which the extract
is fractionated into three lipid moieties and, finally, the
FAMEs are directly produced from the phospholipid fraction.
MIDIFA differs because it instead uses saponification/acid
methanolysis (Sasser 1990; Cavigelli et al. 1995). In the first
two methods, the obtained FAMEs are derived from fatty
acids with ester bonds, while the last method also extracts
other types of fatty acids such as specimens linked by ether
bonds (Sasser 1990; Cavigelli et al. 1995).
Fatty acid conversion in more volatile FAMES is necessary
for the identification of fatty acids in gas chromatography.
Before NMS ordination, chromatogram peak analysis was
performed by relating the area of each peak to the peak area
22 Parasitol Res (2014) 113:19–27
of the fatty acid, 16:0 (palmitic acid). Palmitic acid was
identified with standards such as PUFA and BAME. The
analyzed peaks had minimum integration values equivalent
to 4 % of the area of 16:0. Only peaks eluted between the
retention times of 10.6 and 33 min were included in the
multivariate analysis.
Identification of the other peaks was performed with MS
because there is no current standard or well-defined commer-
cial method of Leishmania fatty acid identification. Figure 1
shows the fatty acid methyl esters chromatogram from the
gas chromatography associated with mass spectrometry (GC-
MS) analysis of all MIDI samples. Table 2 lists the peak
identification.
MIDIFA
ForMIDIFA analyses, each isolate was tested in quadruplicate
(samples A, B, C, and D), except for LVH SE 17, for which
sample Awas lost during the procedures, and the isolate LTCP
9667, for which sample A was an outlier. Thus, the analyses
were performed on a total of 38 samples, and 44 fatty acid
methyl esters were obtained.
An NMS analysis of MIDIFA profile was performed. Each
point (score) in the ordination represents all the fatty acids of
each isolate. Pearson's correlations were used between the
variable values and the isolate scores (determined in a multi-
variate analysis) to characterize the main variations along the
axes. The variable scores express the central tendency and the
range of values for those variables among the samples.
Figure 2 shows the graphic that resulted from the NMS of
the MIDI analysis, grouping the isolates according to NO/
antimony susceptibility. Although the isolates seem to have
overlapped, there were statistically significant differences in
the fatty acid compositions between the NO/antimony-
sensitive and -resistant isolates when L. amazonensis and L.
chagasi were analyzed together. This was clearly observed in
the MRPP statistics that showed a significance value below
0.04 %. Regarding the total data variability, 86 % were
explained by ordination, with 38.8 and 47.2 % of the fatty
acid diversity represented along axes 1 and 2, respectively.
A comparison of the fatty acid profiles also reveals vari-
ability in the fatty acid profiles of the L. chagasi and L.
amazonensis species (Fig. 3). There is a concentration of
scores, thus indicating a distinction between the FAME
profiles.
Notwithstanding, there is greater variability when the data
are organized according to the two variables of NO/ antimony
susceptibility and species, as shown in Fig. 4. A superior
distinction of the profiles, considered significant by the
MRPP test, could also be observed.
Because the MIDI fatty acid profiles differed significantly
between L. amazonensis and L. chagasi and between the
isolates that were resistant or not to NO/trivalent antimony,
an indicator species analysis was performed for each variable
(NO/antimony susceptibility and species). This analysis was
used to identify the fatty acids responsible for greater variabil-
ity between the phenotypes. The most expressive fatty acid
differences are listed in Table 3.
The fatty acid 18:1 Δ9c, oleic acid, was increased in the
sensitive isolates (p <0.001), whereas 20:4 Δ5,8,11,14
showed the opposite trend (p <0.01). The average relative
abundance of the fatty acid 18:1 Δ9c in the four sensitive
isolates was 0.12 %, while in the six resistant isolates, it was
0.06 %. However, the fatty acid 20:4 Δ5,8,11,14 was in-
creased in the resistant isolates, with an average value of
0.20 vs. 0.12 % in the sensitive isolates. According to the
indicator values for species differentiation, two as yet
unidentified fatty acids were increased in L. amazonensis
species (p <0.001).
In the ELFA analyses, 30 samples were used (each isolate
was analyzed in triplicate), and 49 fatty acid methyl esters
were obtained. In the PLFA analyses, 40 samples were used
(each isolate was analyzed in quadruplicate), and 40 fatty acid
methyl esters were obtained. The fatty acid profile analyses
performed with these two techniques showed that there were
no differences in the fatty acid profiles of L. amazonensis and
L. chagasi or between NO/antimony-resistant and -sensitive
Fig. 1 GC-MS chromatogram representative from all the MIDI samples
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Table 2 Fatty acid methyl esters
resulting from the GC-MS MIDI
analysis from all isolates biomass
Peak Retention
time
Compound—fatty acid GC-MS
(%)
GC/FID
(%)
1 11.515 Methyl dodecanoate (C12:0) 0.08 0.0792
2 13.175 Methyl tridecanoate (C13:0) 0.07 0.0638
3 16.880 Methyl tetradecanoate (C14:0) 2.41 2.3182
4 18.570 Methyl pentadecanoate (C15:0) 3.92 3.7191
7 21.570 Cis-9-methyl hexadecanoate (C16:1 Δ9c) 0.11 0,1607
10 22.115 Methyl hexadecanoate (C16:0) 2.56 2.3601
11 23.680 15-methyl methyl hexadecanoate (C16:0i) 1.83 1.7519
12 24.00 Methyl heptadecenoate (C17:1) 0.4 0.4417
13 24.595 Methyl heptadecenoate (C17:1) 0.87 0.7812
14 26.005 6,9,12-methyl octadecatrienoate (C18:3 Δ6c,9c,12c) 20.34 21.4975
15 26.370 Cis-9,12-methyl octadecadienoate (C18:2 Δ9c, 12c) 12.44 12.4524
16 26.525 Cis-9-methyl octadecatrienoate (C18:1 Δ9c) 15.14 16.1968
17 26.605 Trans-9-methyl octadecatrienoate (C18:1 Δ9 t) 0.62 –
18 27.075 Methyl octadecanoate (C18:0) 10.51 10.3550
22 29.000 Cis-9,10-methylene methyl octadienoate (C19:0 cy9c) 12.94 11.5237
23 28.460 Methyl nonadecanoate (C19:0) 0.09 0.0319
24 30.145 Cis-5,8,11,14-methyl eicosatetranoate (C20:4Δ5c,8c,11c,14c) 0.10 0.0733
25 30.605 8,11,14-methyl eicosatrienoate (C20:3 Δ8,11,14) 0.64 0.6714
26 31.085 11,14-methyl eicosadienoate (C20:3 Δ5,8,11c,14c) 0.10 0.0733
27 31.895 Methyl eicosanoate (C20:0) 0.15 0.1377
28 32.725 5,8,11,14-methyl eicosatetranoate (C20:4 Δ5,8,11,14) 0.29 0.2751
31 36.425 Cis-5,8,11,14,17-methyl eicosapentaenoate (C20:5 Δ5c,8c,
11c,14c,17c) – EPA
1.66 1.8845
Fig. 2 NMS representation of the sample distance according to the
MIDIFA composition separating the antimony/NO-resistant isolates and
the sensitive ones. Continuous line encloses the study groups. The
proportion of variance explained by each axis is based on the correlation
(R between distance in the reduced NMS space and the original space; it
is reported after each axis heading). MRPP test: p =0.00036787;
A=0.05103330
Fig. 3 L. amazonensis vs L. chagasi NMS graphic representation of the
sample distance according to the MIDIFA composition grouping the
isolates according to species. Continuous lines enclose the study groups.
The proportion of variance explained by each axis is based on the
correlation (R between distance in the reduced NMS space and the
original space; it is reported after each axis heading). MRPP test:
p =0.00489206; A=0.03432629
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isolates. The MRPP results from the NMS ordination of the
ELFA and PLFA analysis yielded no statistically significant
results, as shown in Table 4.
Discussion
Fatty acids are commonly used as biomarkers to profile mi-
crobial communities or for bacterial identification (Sasser
1990; Schutter and Dick 2000; Buttler et al. 2003;
Lanoiselet et al. 2005). Fatty acid methyl ester (FAMEs)
profiles from isolates of trivalent antimony and nitric oxide-
resistant and -sensitive L. amazonensis and L. chagasi were
produced by three different methods of fatty acid extraction:
ELFA, PLFA, and MIDI. Hence, the presented results showed
that MIDI-FAME profiles differed between L. amazonensis
and L. chagasi and between isolates resistant or not to NO/
trivalent antimony. The MIDI procedure was originally devel-
oped to produce FAMEs from bacterial cells to identify
strains based on their lipid profiles. This method also seems
useful when differentiating Leishmania species and isolates with
different phenotypes. Differences in phospholipid-derived fatty
acids in antimonial drug-sensitive and -resistant L. donovani
isolates were also reported by T'kindt et al. (2010). Previously,
Rakotomanga et al. (2005) had already reported changes in
the lipid composition of miltefosine-resistant L. donovani
promastigotes when compared to sensitive promastigotes.
Interestingly, there were no significant differences among
the fatty acid profiles obtained by PLFA, which extracts only
phospholipid fatty acids, and ELFA, which extracts fatty acids
from neutral lipids, phospholipids, and glycolipids. However,
the fatty acid profiles obtained with each method of extraction
were different. These differences are expected because PLFA
yields FAME profiles comprised exclusively of phospho-
lipids. Furthermore, the amounts of fatty acids extracted by
MIDIFA and ELFA differ. ELFA extracts FAMEs from three
lipid classes: neutral lipids, phospholipids, and glycolipids
(Schtter and Dick 2000); however, MIDIFA also extracts
dimethylacetals (derived from ester bonds) and other com-
pounds that might be derived from the sphingolipid fatty acids
(Kates 1986). This occurs because MIDI employs a
saponification/acid methylation reaction, while ELFA is based
on a mild alkaline methanolysis.
It is notable that the fatty acid profiles analyzed by NMS
emphasize the differences in the relative compositions of fatty
acids in the samples, rather than differences in the absolute
amounts.
The MIDIFA technique employed in this study might have
analyzed some of the sphingolipid fatty acid residues in the as
yet unidentified molecules. The sphingolipids are ubiquitous
components of eukaryotic membranes, where they have roles
in membrane physiology, cellular signaling, and lipid raft for-
mation (Zhang et al. 2009; Zhang et al. 2010). These findings
suggest the importance of sphingolipids asmolecular targets and
suggest that SLs should be studied carefully and could possibly
provide a biomarker or drug target for leishmaniasis treatment.
Once MIDI fatty acids profiles could differentiate between
both Leishmania species and between the isolates according
to their viability in the presence of NO/trivalent antimony, we
performed an ISA analysis to search for fatty acids that could
Fig. 4 NMS graphic representation of the sample distance according to
the MIDIFA composition grouping the isolates according to species and
also to NO/antimony susceptibility. The proportion of variance explained
by each axis is based on the correlation (R between distance in the
reduced NMS space and the original space; it is reported after each axis
heading). MRPP test: p =0.00009271; A=0.07796919
Table 3 MIDI Indicator values as the NO/antimony susceptibility
Fatty acid Indicator value
(IV)
Expressive group pa
18:1 Δ9c 63 34 NO/Antimony Sensitive 0.0002
20:4 Δ5,8,11,14 24 63 NO/Antimony Resistant 0.0038
aMonte Carlo test of significance
Table 4 MRPP results of NMS ordination from ELFA and PLFA anal-
ysis of the L. chagasi and L. amazonensis isolates relating the resistance
and sensibility to NO/antimony, the species and both characteristics
ELFA PLFA
P A P A
Sensibility 0.26007990 0.00482760 0.30770480 0.00172086
Specie 0.01837509 0.04369502 0.31499664 0.00184066
Sensibility/
Specie
0.08801758 0.04781894 0.34227467 0.00637848
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be relevant in the profile differences. In fact, these analyses
revealed that the fatty acid 18:1Δ9c (oleic acid) was increased
in the sensitive isolates, whereas the fatty acid 20:4 Δ5,8,11,
14 showed the opposite trend. The perspective is that these
fatty acids could be used as biomarkers to identify NO- and
antimony-susceptible Leishmania isolates.
The finding that the fatty acid 20:4 Δ5,8,11,14 was in-
creased proportionally in the resistant isolates is consistent
because fatty acyl unsaturation is generally thought to de-
crease the ordered states of membranes and increase mem-
brane fluidity (Hsu Chen and Feingold 1973; Mbongo et al.
1998). In fact, increased fatty acid unsaturation has already
been reported in Leishmania parasites that were resistant to
several other drugs, including miltefosine (Rakotomanga et al.
2005), amphotericin B (Mbongo et al. 1998), atovaquone
(Cauchetier et al. 2002), and pentamidine (Basselin and
Robert-Gero 1998). These changes in the alkyl chain compo-
sitions of plasma membrane lipids could modulate drug–
membrane interactions and possibly be involved in drug re-
sistance. Such changes in membrane lipid metabolism were
also demonstrated to possibly affect interactions between
drugs and the plasma membrane as well as subsequent drug
uptake (Basselin and Robert-Gero 1998; Mbongo et al. 1998;
Cauchetier et al. 2002; Rakotomanga et al. 2005). Thus, a
higher proportion of the fatty acid 20:4 Δ5,8,11,14 in the
major phospholipids of antimony-resistant L. chagasi isolates
could have an effect upon the antimonial transport and result
in modified antimonial susceptibility in these parasites, as
previously proposed by T'Kindt et al. 2010.
Furthermore, two other as yet unidentified peaks, with
retention times of 20.28 and 20.84 min, were found to be more
highly expressed in L. amazonensis . For this reason, these fatty
acids are potential candidate biomarkers for L. amazonensis
identification. However, due to the small number of available
L. amazonensis isolates, we cannot ensure that these peakswill
behave similarly in a larger number of isolates. Thus, further
studies are needed to confirm these findings.
In conclusion, these findings are important because, be-
sides Leishmania species differentiation, they could provide
biomarkers for NO and trivalent antimony resistance and
sensitivity. These biomarkers should, in the future, facilitate
the rapid introduction of correct therapies to patients and
provide new insights for the creation of more effective leish-
maniasis treatments.
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